A malaria parasite toxin associated with Plasmodium vivax paroxysms

Clinical and Experimental Immunology

Volumn 104, Issue 2, 1996, Pages 221-227

  Wijesekera, S K ^a   Carter, R ^b   Rathnayaka, L ^a   Mendis, K N ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Clinical immunity; Malaria toxin; Paroxysms; Pathogenesis; Plasmodium vivax malaria

Indexed keywords

TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEVER; HUMAN; MALARIA; PLASMODIUM VIVAX; PRIORITY JOURNAL;

EID: 0029915760     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.07699.x     Document Type: Article

References (12)

1. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. Dynamics of fever and serum levels of tumour necrosis factor are closely associated during clinical paroxysms in non-immune Plasmodium vivax malaria patients. Proc Natl Acad Sci USA 1992;89:3200-3.
2. Kwiatkowski D, Molyneux ME, Stephens S et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 1993;86:91-98.
3. Karunaweera ND, Carter R, Grau GE, Kwiatkowski D, Del Giudice G, Mendis KN. Tumour necrosis factor dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin Exp Immunol 1992;88: 499-505.
4. Naotunne T de S, Karunaweera ND, Mendis KN, Carter R. Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology 1993;78:555-62.
5. Clark IA, Rockett KA, Cowden WB. Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol Today 1991;7:205-7.
6. Fonseka J, Mendis KN. A metropolitan hospital in non-endemic area provides a sampling pool for epidemiological studies on vivax malaria in Sri Lanka. Trans Roy Soc Trop Med Hyg 1987;81: 360-4.
7. Mendis C, Gamage-Mendis AC, De Zoysa APK, Abhayawardena TA, Carter R, Herath PRJ, Mendis KN. Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immunoepidemiological studies. Am J Trop Med Hyg 1990;42:298-308.
8. Karunaweera ND. An investigation into clincial disease and clinical immunity to P. vivax malaria. PhD thesis. University of Colombo, Colombo, Sri Lanka, 1993.
9. Ihalamulla RL, Mendis KN. Plasmodium vivax: isolation of mature asexual stages and gametocytes from human blood by colloidal silica (Percoll) gradient centrifugation. Trans Roy Soc Trop Med Hyg 1987;81:25-28.
10. Bate CAW, Taverne J, Karunaweera ND, Mendis KN, Kwiatkowski D, Playfair JHL. Serological relationship of TNF-inducing exoantigens of P. falciparum and P. vivax. Infect Immun 1992;60:1241-3.
11. Mendis KN, Carter R. Clinical disease and pathogenesis in malaria. Parasitol Today 1995;11(Suppl.):PT 1-16.
12. Schofield L, Hackett F. Signal transduction in host cells by glycosyl-phosphatidylinositol toxin of malaria parasites. J Exp Med 1993; 177:145-53.